Production of ColE1 Type Plasmid by Escherichia coli Cultured Under Nonselective Conditions |
PASSARINHA L. A.
(Centro de Engenharia Biologica e Quimica, Instituto Superior Tecnico, Departamento de Quimica, Universidade da Beira Interior)
DIOGO M. M. (Centro de Engenharia Biologica e Quimica, Instituto Superior Tecnico) QUEIROZ J. A. (Departamento de Quimica, Universidade da Beira Interior) MONTEIRO G. A. (Centro de Engenharia Biologica e Quimica, Instituto Superior Tecnico) FONSECA L. P. (Centro de Engenharia Biologica e Quimica, Instituto Superior Tecnico) PRAZERES D. M. F. (Centro de Engenharia Biologica e Quimica, Instituto Superior Tecnico) |
1 | CBER. 1996. Points to consider on plasmid DNA vaccines for preventive infectious disease indications. US FDA. Rockville, MD, U.S.A |
2 | Diogo, M. M., J. A. Queiroz, and D. M. F. Prazeres. 2003. Assessment of purity and quantification of plasmid DNA in process solutions using high-performance hydrophobic interaction chromatography. J. Chromatogr. A. 998: 109-117 DOI ScienceOn |
3 | Chen, W. 1999. Automated high-yield fermentation of plasmid DNA in Escherichia coli. American Home Products Corporation. US Patent: 5955323 |
4 | Summers, D. K. 1991. The kinetics of plasmid loss. Trends Biotechnol. 9: 273-278 DOI ScienceOn |
5 | Williams, S. G., R. M. Cranenburgh, A. M. E. Weiss, C. J. Wrighton, D. J. Sherratt, and J. A. J. Hanak. 1998. Repressor titration: A novel system for selection and stable maintenance of recombinant plasmids. Nucleic Acids Res. 26: 2120- 2124 DOI |
6 | Chen, W., C. Graham, and R. B. Ciccarelli. 1997. Automated fed-batch fermentation with feed-back controls based on dissolved oxygen (DO) and pH for production of DNA vaccines. J. Ind. Microbiol. Biotechnol. 18: 43-48 DOI |
7 | Birnboim, H. C. and J. Doly. 1979. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res. 7: 1513-1523 DOI ScienceOn |
8 | Summers, D. 1998. Timing, self-control and a sense of direction are the secrets of multicopy plasmid stability. Mol. Microbiol. 29: 1137-1145 DOI ScienceOn |
9 | Wang, Z., G. Le, Y. Shi, and G. Wegrzyn. 2001. Medium design for plasmid DNA production based on stoichiometric model. Process Biochem. 36: 1085-1093 DOI ScienceOn |
10 | Lahijani, R., G. Hulley, G. Soriano, N. A. Horn, and M. Marquet. 1996. High-yield production of pBR322-derived plasmids intended for human gene therapy by employing a temperature controllable point mutation. Hum. Gene Ther. 7: 1971-1980 DOI ScienceOn |
11 | Prazeres, D. M. F., G. N. M. Ferreira, G. A. Monteiro, C. L. Cooney, and J. M. S. Cabral. 1999. Large-scale production of pharmaceutical-grade plasmid DNA for gene therapy: Problems and bottlenecks. Trends Biotechnol. 17: 169-174 DOI ScienceOn |
12 | Prather, K. J., S. Sagar, J. Murphy, and M. Chartrain. 2003. Industrial scale production of plasmid DNA for vaccine and gene therapy: Plasmid design, production and purification. Enzyme Microb. Technol. 33: 865-883 DOI ScienceOn |
13 | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Handbook. CSH Laboratory Press, Cold Spring Harbor, U.S.A |